ru
ru

A pharmacist from Syria will study for a master's degree at the Faculty of Biology of CSU

Alnassaf Nour from Damascus entered the master's programme at the Faculty of Biology of Chelyabinsk State University under the quota of the Russian Government for foreign citizens. She will study the master's programme ‘Biotechnology’ for two years.

At the moment, 12 people study at our university under the quota of the Government of the Russian Federation for foreign citizens - at the Faculty of Economics, Faculty of Physics, Faculty of Mathematics, Faculty of Linguistics and Translation, Institute of Economics of Industries, Business and Administration, Institute of Education and Practical Psychology, Institute of Law.

Alnassaf Nour came to Russia a year ago: all this time she has been a student of the Faculty of History and Philology of CSU, attending classes at the Department of Russian as a Foreign Language. Her knowledge of the language will allow her to study at the Master's programme on an equal footing with Russian-speaking students. In addition, within the quota, the student will receive a scholarship for the entire period of her studies, and will also be able to participate in increased scholarship programmes.

Before coming to Russia, Nour worked as a pharmacist at the Higher Institute of Applied Sciences and Technology in Damascus. Her employer sent her to study: the Biotechnology programme of our Faculty of Biology showed that it met all the necessary parameters and opened up career prospects for her.

‘After I finish my master's degree, I will have a higher position, and I will also be able to do everything I learn here in two years in the lab. In the future I would like to be in charge of the lab, do research with plants and animals, and create medicines. I want to learn and master new technologies that I didn't know before,’ says Nur.

The Master's programme Biotechnology provides fundamental knowledge of cell and molecular biology, organisation of biological laboratories and a wide range of biotechnological disciplines. The head of the programme is Professor of the Department of Microbiology, Immunology and General Biology, Doctor of Sciences (in Biology) Yulia Filippova.

‘An important feature of the programme is the practice-oriented approach,’ comments the professor. - From the first days of study, a master's student is involved in the fulfilment of scientific work. The range of conducted research is extremely wide: from microclonal plant propagation to immunogenetics and bioprinting of human organs. No less valuable is the fact that some of the work is carried out at the request of employers in the region. For example, in the new academic year, together with the DNA Clinic, our master's students will be looking for pharmacogenetic markers of therapy efficiency in oncological diseases. The work will be carried out on equipment unique for the region - digital PCR, which was purchased for the collective use centre of CSU as part of the programme to create a World-Class Campus’.

Biotechnology remains one of the most promising specialities, as it makes it possible to meet the great challenges of our time at a new technological level: from the problem of increasing plant yields and obtaining improved animal breeds to the creation of new-generation drugs for the development of personalised medicine, from the production of energy from renewable raw materials to the use of environmental biotechnology as the latest approach to the preservation of the planet.

‘The programme also attracts international students, as it gives them the opportunity to implement an individual educational trajectory and interdisciplinary approach,’ says Yulia Filippova. - Practical training of master's students takes place in research institutes and laboratories not only in Chelyabinsk, but also in the State Research Centre for Applied Microbiology and Biotechnology in Obolensk and in the pharmaceutical company Biocad in Moscow. Our biotechnology graduates are in demand on the labour market and currently work in pharmaceutical companies and research institutes in Russia, such as Biomerie and the Russian Research Institute of Haematology and Transfusiology of the Federal Medical and Biological Agency’.

Did you find a misprint?
Select it, press Ctrl+Enter and send us a notification. Thank you for participating!

Spelling error in the text

Send a bug report to the author?
Your browser will remain on the same page.

Version for the visually impaired

Color scheme: